1-3 of 3
holmium-166
Close
Sort by
Journal Articles

Holmium-166 ( 166 Ho)-DOTMP Skeletal Targeted Radiotherapy (STR ™ ) with Melphalan and Autologous Peripheral Stem Cell Transplant (PBSCT) for Multiple Myeloma (MM).

Mark Goodman, M.D., William I. Bensinger, M.D., Sergio Giralt, M.D, Donna Salzman, M.D., Katherine L. Ruffner, M.D., Hazel B. Breitz, M.D.
Journal: Blood
Blood (2004) 104 (11): 922.
https://doi.org/10.1182/blood.V104.11.922.922
Published: 2004
Journal Articles

Targeted Radiotherapy to the Skeleton Using 166Ho-DOTMP with Autologous Stem Cell Transplantation for Patients with Bone-Only Metastatic Breast Cancer.

Richard Champlin, M.D., Daniel Booser, M.D., Gabriela Rondon, M.D., Patricia Williams, R.N., Richard Wendt, Ph.D., Gabriel Hortobagyi, M.D., Naoto Ueno, M.D., Donald Podoloff, M.D.
Journal: Blood
Blood (2004) 104 (11): 5239.
https://doi.org/10.1182/blood.V104.11.5239.5239
Published: 2004
Journal Articles

166 Ho-DOTMP plus melphalan followed by peripheral blood stem cell transplantation in patients with multiple myeloma: results of two phase 1/2 trials

Clinical Trials & Observations
Sergio Giralt, William Bensinger, Mark Goodman, Donald Podoloff, Janet Eary, Richard Wendt, Raymond Alexanian, Donna Weber, David Maloney, Leona Holmberg, Joseph Rajandran, Hazel Breitz, Richard Ghalie, Richard Champlin
Journal: Blood
Blood (2003) 102 (7): 2684–2691.
https://doi.org/10.1182/blood-2002-10-3250
Published: 2003